Neoplasms, Liver
8
0
0
4
Key Insights
Highlights
Success Rate
57% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
37.5%
3 terminated out of 8 trials
57.1%
-29.4% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
NOLA (NeuWave Observational Liver Ablation) Registry
Ablation Confirmation Study
Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors
Study of New Software Used During Ablations
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients
Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma